{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:03:32Z","timestamp":1760061812279},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bbr.2005.05.005","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T09:41:54Z","timestamp":1119606114000},"page":"212-218","source":"Crossref","is-referenced-by-count":23,"title":["The \u03ba-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety"],"prefix":"10.1016","volume":"163","author":[{"given":"Eva Maria","family":"Marco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"P\u00e9rez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paz","family":"Viveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2005.05.005_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0926-6917(93)90009-F","article-title":"Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior","volume":"248","author":"Aceto","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.05.005_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00213-003-1595-7","article-title":"Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats","volume":"171","author":"Araki","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-005-2238-y","article-title":"Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice","author":"Balerio","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.05.005_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000123364","article-title":"Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides","volume":"35","author":"Buckingham","year":"1982","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbr.2005.05.005_bib5","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.bbr.2005.05.005_bib6","series-title":"Experimental approaches to anxiety and depression","first-page":"25","article-title":"Behavioral detection of anxiolytic action","author":"File","year":"1992"},{"key":"10.1016\/j.bbr.2005.05.005_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00421184","article-title":"Validity of head-dipping as a measure of exploration in a modified hole-board","volume":"44","author":"File","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.bbr.2005.05.005_bib8","first-page":"443","article-title":"Role of nitric oxide in the nicotine-induced pituitary-adrenocortical response","volume":"55","author":"Gadek-Michalska","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.bbr.2005.05.005_bib9","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/S0028-3908(00)00119-2","article-title":"Kappa-opioid receptor modulation of nicotine-induced behaviour","volume":"39","author":"Hahn","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.05.005_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0091-3057(93)90378-7","article-title":"Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide","volume":"46","author":"Huston-Lyons","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.05.005_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0304-3940(02)00074-5","article-title":"Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats","volume":"323","author":"Ise","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2005.05.005_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/070674379804300103","article-title":"Nicotine and endogenous opioids: toward specific pharmacotherapy","volume":"43","author":"Ismail","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.bbr.2005.05.005_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1460-9568.2000.00012.x","article-title":"Dynorphins directly inhibit neuronal nicotinic acetylcholine receptors in PC12 cells","volume":"12","author":"Itoh","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2005.05.005_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0024-3205(82)90407-6","article-title":"ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats","volume":"31","author":"Jezova","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2005.05.005_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0031-9384(96)00103-5","article-title":"Reductions in locomotor activity following central opioid receptor subtype antagonists in rats","volume":"60","author":"Leventhal","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2005.05.005_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02244930","article-title":"Naloxone precipitates nicotine abstinence syndrome in the rat","volume":"112","author":"Malin","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.05.005_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the \u03ba-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Mar\u00edn","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.05.005_bib18","first-page":"217","article-title":"Nicotine elevates rat plasma ACTH by a central mechanism","volume":"243","author":"Matta","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2005.05.005_bib19","first-page":"635","article-title":"The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic\u2013pituitary\u2013adrenal axis responses","volume":"288","author":"Mellon","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2005.05.005_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s004240050719","article-title":"Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells","volume":"436","author":"Oka","year":"1998","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.bbr.2005.05.005_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)01966-6","article-title":"Extrahypothalamic corticotropin-releasing hormone mediates (\u2212)-nicotine-induced elevation of plasma corticosterone in rats","volume":"473","author":"Okada","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.05.005_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3940(93)90289-W","article-title":"The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat","volume":"161","author":"Okuda","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2005.05.005_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002130050976","article-title":"Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine","volume":"144","author":"Ouagazzal","year":"1999","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.bbr.2005.05.005_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.pa.33.040193.002033","article-title":"Effects of opioids on the hypothalamus\u2013pituitary\u2013adrenal axis","volume":"33","author":"Pechnick","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2005.05.005_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arms entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.bbr.2005.05.005_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0306-4530(97)00074-7","article-title":"Endogenous opioids and smoking: a review of progress and problems","volume":"23","author":"Pomerleau","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2005.05.005_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0306-4522(01)00264-0","article-title":"Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens","volume":"106","author":"Schmidt","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2005.05.005_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0143-4179(96)90013-X","article-title":"Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse","volume":"30","author":"Suh","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2005.05.005_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-003-1403-4","article-title":"Corticotropin releasing factor antagonist, alpha-helical CRF (9\u201341), reverses nicotine-induced conditioned, but not unconditioned, anxiety","volume":"167","author":"Tucci","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.05.005_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.fbp.0000081782.35927.c6","article-title":"Do different mechanisms underlie two anxiogenic effects of systemic nicotine?","volume":"14","author":"Tucci","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2005.05.005_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0361-9230(01)00760-2","article-title":"Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates","volume":"57","author":"Urig\u00fcen","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2005.05.005_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-3057(00)00457-3","article-title":"The possible cross-tolerance between morphine- and nicotine-induced hypothermia in mice","volume":"68","author":"Zarrindast","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.05.005_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(02)01002-X","article-title":"Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice","volume":"74","author":"Zarrindast","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.05.005_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0924-977X(96)00002-8","article-title":"Nicotine potentiates morphine antinociception: a possible cholinergic mechanism","volume":"6","author":"Zarrindast","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2005.05.005_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0091-3057(01)00754-7","article-title":"Nicotine potentiation of morphine-induced catalepsy in mice","volume":"72","author":"Zarrindast","year":"2002","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432805002093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432805002093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T21:04:32Z","timestamp":1551301472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432805002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0166432805002093"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2005.05.005","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}